What does CUSIP 640268108 represent in this 13F holders report?

CUSIP 640268108 is the security identifier for NKTR - Nektar Therapeutics - Common Stock used to aggregate holder disclosures.

How many institutions held NKTR - Nektar Therapeutics - Common Stock in Q2 2018?

368 institutional investors reported NKTR - Nektar Therapeutics - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Nektar Therapeutics - Common Stock (NKTR)

CUSIP: 640268108

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 20,788,527
Total 13F shares: 160,416,782
Share change: +3,186,308
Total reported value: $7,832,434,531
Put/Call ratio: 46%
Price per share: $48.83
Number of holders: 368
Value change: -$143,968,898
Number of buys: 216
Number of sells: 199

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 640268108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	116%	24,097,068	$2,560,554,000	—	31 Mar 2018	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	101%	21,061,895	$2,238,037,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	83%	17,229,321	$1,830,788,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	70%	14,471,008	$1,537,689,000	—	31 Mar 2018	13F
OppenheimerFunds, Inc.	13F	Company	52%	10,715,522	$1,138,631,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	30%	6,326,603	$672,266,000	—	31 Mar 2018	13F
JANUS HENDERSON GROUP PLC	13F	Company	25%	5,282,811	$561,119,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	17%	3,474,653	$369,216,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	15%	3,158,233	$335,594,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	13%	2,605,818	$276,893,000	—	31 Mar 2018	13F
Cormorant Asset Management, LP	13F	Company	12%	2,563,200	$272,366,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	9.8%	2,042,359	$216,685,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	7.3%	1,518,156	$161,319,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	7.2%	1,502,673	$159,674,000	—	31 Mar 2018	13F
Camber Capital Management LP	13F	Company	7.2%	1,500,000	$159,390,000	—	31 Mar 2018	13F
NORGES BANK	13F	Company	6.8%	1,405,805	$149,381,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	6.2%	1,288,568	$136,924,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	6.1%	1,277,484	$135,745,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	6.1%	1,266,915	$134,622,000	—	31 Mar 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	5.9%	1,219,087	$129,540,000	—	31 Mar 2018	13F
Duquesne Family Office LLC	13F	Company	5.7%	1,192,300	$126,694,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	5.6%	1,158,240	$123,075,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	5.2%	1,076,828	$114,424,000	—	31 Mar 2018	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	4.9%	1,013,932	$107,740,000	—	31 Mar 2018	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	4.9%	1,009,601	$107,280,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	4.8%	1,007,003	$107,004,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	4%	837,064	$88,946,000	—	31 Mar 2018	13F
FIRST TRUST ADVISORS LP	13F	Company	3.5%	731,882	$77,770,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	3.5%	730,167	$77,588,000	—	31 Mar 2018	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	3.4%	715,571	$76,037,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	3.4%	700,000	$74,382,000	—	31 Mar 2018	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	3.3%	676,058	$71,838,000	—	31 Mar 2018	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	3.5%	720,425	$71,156,000	—	31 Mar 2018	13F
BRIDGER MANAGEMENT, LLC	13F	Company	3.2%	668,492	$71,034,000	—	31 Mar 2018	13F
FRANKLIN RESOURCES INC	13F	Company	3.2%	655,400	$69,643,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	3.1%	644,401	$68,474,000	—	31 Mar 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	3%	629,361	$66,875,000	—	31 Mar 2018	13F
PointState Capital LP	13F	Company	3%	623,316	$66,234,000	—	31 Mar 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	2.9%	610,157	$64,835,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	2.8%	575,008	$61,099,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	2.7%	564,101	$59,941,000	—	31 Mar 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	2.4%	488,894	$51,950,000	—	31 Mar 2018	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	2.2%	460,993	$48,985,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2.1%	437,641	$46,504,000	—	31 Mar 2018	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	2%	413,147	$43,901,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	1.9%	391,985	$41,653,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	1.9%	384,978	$40,908,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	1.8%	377,708	$40,135,000	—	31 Mar 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	1.8%	366,564	$38,951,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	1.7%	361,330	$38,395,000	—	31 Mar 2018	13F

Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q2 2018

As of 30 Jun 2018, Nektar Therapeutics - Common Stock (NKTR) was held by 368 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 160,416,782 shares. The largest 10 holders included FMR LLC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., OppenheimerFunds, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, and Invesco Ltd.. This page lists 369 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

349

Q2 2018 holders

368

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.